C. Sternini et al., AGONIST-SELECTIVE ENDOCYTOSIS OF MU-OPIOID RECEPTOR BY NEURONS IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 93(17), 1996, pp. 9241-9246
Opiate alkaloids are potent analgesics that exert multiple pharmacolog
ical effects in the nervous system by activating G protein-coupled rec
eptors. Receptor internalization upon stimulation may be important for
desensitization and resensitization, which affect cellular responsive
ness to ligands. Here, we investigated the agonist-induced internaliza
tion of the mu opioid receptor (MOR) in vivo by using the guinea pig i
leum as a model system and immunohistochemistry with an affinity-purif
ied antibody to the C terminus of rat MOR, Antibody specificity was co
nfirmed by the positive staining of human embryonic kidney 293 cells t
ransfected with epitope-tagged MOR cDNA, by the lack of staining of ce
lls transfected with the delta or kappa receptor cDNA, and by the abol
ition of staining when the MOR antibody was preadsorbed with the MOR p
eptide fragment, Abundant MOR immunoreactivity (MOR-IR) was localized
to the cell body, dendrites, and axonal processes of myenteric neurons
, Immunostaining was primarily confined to the plasma membrane of cell
bodies and processes. Within 15 min of an intraperitoneal injection o
f the opiate agonist etorphine, intense MOR IR was present in vesiclel
ike structures, which were identified as endosomes by confocal microsc
opy, At 30 min, MOR-IR was throughout the cytoplasm and in perinuclear
vesicles, MOR-IR was still internalized at 120 min, Agonist-induced e
ndocytosis was completely inhibited by the opiate antagonist naloxone.
Interestingly, morphine, a high-affinity MOR agonist, did not cause d
etectable internalization, but it partially inhibited the etorphine-in
duced MOR endocytosis. These results demonstrate the occurrence of ago
nist-selective MOR endocytosis in neurons naturally expressing this re
ceptor in vivo and suggest the existence of different mechanisms regul
ating cellular responsiveness to ligands.